FONTEYNE PAUL R. 4
4 · Amylyx Pharmaceuticals, Inc. · Filed Jun 12, 2023
Insider Transaction Report
Form 4
FONTEYNE PAUL R.
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-08+16,985→ 16,985 totalExercise: $26.25Exp: 2033-06-08→ Common Stock (16,985 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in full upon the earlier of (i) June 8, 2024 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.